Diverse NO reduction by Halomonas halodenitrificans nitric oxide reductase. 2005

Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
Division of Material Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kakuma, Kanazawa 920-1192, Japan. ts0513@kenroku.kanazawa-u.ac.jp

Reduction of the four Fe centers is not required to initiate the reaction of the Halomonas halodenitrificans nitric oxide reductase (NOR) based on the facts that NOR in the form that ferric heme b(3) and non-heme iron (Fe(B)) are not bridged and/or the interaction between them is weakened and reversibly binds NO molecules, and that NOR in the form that only heme b(3) is oxidized reacts with NO molecules.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D020632 Halomonas A genus of gram-negative, rod-shaped or pleomorphic bacteria which are halotolerant. Members of this genus are capable of growth in sodium chloride concentrations of up to 20% or more. (From Bergey's Manual of Determinative Bacteriology, 9th ed) Halomonas elongata

Related Publications

Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
April 2017, Journal of inorganic biochemistry,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
November 1997, Biochemistry,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
October 1998, Biochemical and biophysical research communications,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
January 2008, Journal of inorganic biochemistry,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
April 2006, Biochimica et biophysica acta,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
January 2000, Folia microbiologica,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
July 2016, Journal of computational chemistry,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
July 2013, Biochimica et biophysica acta,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
July 1998, Biochemistry. Biokhimiia,
Takeshi Sakurai, and Shoko Nakashima, and Kunishige Kataoka, and Daisuke Seo, and Nobuhiko Sakurai
January 2001, Advances in experimental medicine and biology,
Copied contents to your clipboard!